Search research articles
Contact Us
Filters
Showing results (31-40 of 102) with videos related to
Page
of 11
Sort By:
Journal of Developmental and Behavioral Pediatrics : JDBP
|
March 27, 2001
Mediators of behavioral problems in 7-year-old children born after 24 to 28 weeks of gestation
L Nadeau, M Boivin, R Tessier, et al.
Bordeaux Medical
|
July 1, 1970
[Tuberculous meningitis. Apropos of 15 cases]
G Courty, P Martre, P Guimont, et al.
International Journal of Antimicrobial Agents
|
October 1, 1996
Influence of ticlopidine on the development of experimental Staphylococcus aureus endocarditis
D P Nicolau, P R Tessier, C H Nightingale, et al.
Die Pharmazie
|
May 3, 2006
In vivo immunomodulatory profile of telithromycin in a murine pneumococcal infection model
D P Niclau, p R Tessier, I Rubinstein, et al.
Heliyon
|
July 29, 2024
Peptide nucleic acids (PNAs) control function of SARS-CoV-2 frameshifting stimulatory element trough PNA-RNA-PNA triplex formation
Md Motiar Rahman, Christopher A Ryan, Brandon R Tessier, et al.
Disease Models & Mechanisms
|
May 6, 2010
Fragile X mental retardation protein has a unique, evolutionarily conserved neuronal function not shared with FXR1P or FXR2P
R Lane Coffee, Charles R Tessier, Elvin A Woodruff, et al.
International Journal of Antimicrobial Agents
|
May 9, 1998
Influence of adjunctive ticlopidine on the treatment of experimental Staphylococcus aureus endocarditis
D P Nicolau, P R Tessier, C H Nightingale, et al.
Antimicrobial Agents and Chemotherapy
|
April 29, 1998
Synergistic activity of trovafloxacin and ceftriaxone or vancomycin against Streptococcus pneumoniae with various penicillin susceptibilities
D P Nicolau, P R Tessier, R Quintiliani, et al.
The Journal of Antibiotics
|
February 28, 2007
Bactericidal efficacy of ABI-0043, a novel rifamycin, in a murine pneumococcal pneumonia model
Su Young Lee, Pamela R Tessier, Christopher K Murphy, et al.
Chemotherapy
|
July 8, 1999
Pharmacodynamics of intermittent- and continuous-infusion cefepime alone and in combination with once-daily tobramycin against Pseudomonas aeruginosa in an in vitro infection model
P R Tessier, D P Nicolau, C O Onyeji, et al.
Page
of 11
Search research articles
Search
Showing results (31-40 of 102) with videos related to
Sort By:
Page
of 11
Journal of Developmental and Behavioral Pediatrics : JDBP
|
March 27, 2001
Mediators of behavioral problems in 7-year-old children born after 24 to 28 weeks of gestation
L Nadeau, M Boivin, R Tessier, et al.
Bordeaux Medical
|
July 1, 1970
[Tuberculous meningitis. Apropos of 15 cases]
G Courty, P Martre, P Guimont, et al.
International Journal of Antimicrobial Agents
|
October 1, 1996
Influence of ticlopidine on the development of experimental Staphylococcus aureus endocarditis
D P Nicolau, P R Tessier, C H Nightingale, et al.
Die Pharmazie
|
May 3, 2006
In vivo immunomodulatory profile of telithromycin in a murine pneumococcal infection model
D P Niclau, p R Tessier, I Rubinstein, et al.
Heliyon
|
July 29, 2024
Peptide nucleic acids (PNAs) control function of SARS-CoV-2 frameshifting stimulatory element trough PNA-RNA-PNA triplex formation
Md Motiar Rahman, Christopher A Ryan, Brandon R Tessier, et al.
Disease Models & Mechanisms
|
May 6, 2010
Fragile X mental retardation protein has a unique, evolutionarily conserved neuronal function not shared with FXR1P or FXR2P
R Lane Coffee, Charles R Tessier, Elvin A Woodruff, et al.
International Journal of Antimicrobial Agents
|
May 9, 1998
Influence of adjunctive ticlopidine on the treatment of experimental Staphylococcus aureus endocarditis
D P Nicolau, P R Tessier, C H Nightingale, et al.
Antimicrobial Agents and Chemotherapy
|
April 29, 1998
Synergistic activity of trovafloxacin and ceftriaxone or vancomycin against Streptococcus pneumoniae with various penicillin susceptibilities
D P Nicolau, P R Tessier, R Quintiliani, et al.
The Journal of Antibiotics
|
February 28, 2007
Bactericidal efficacy of ABI-0043, a novel rifamycin, in a murine pneumococcal pneumonia model
Su Young Lee, Pamela R Tessier, Christopher K Murphy, et al.
Chemotherapy
|
July 8, 1999
Pharmacodynamics of intermittent- and continuous-infusion cefepime alone and in combination with once-daily tobramycin against Pseudomonas aeruginosa in an in vitro infection model
P R Tessier, D P Nicolau, C O Onyeji, et al.
Page
of 11